4.2 Article

Nuclear assembly as a target for anti-cancer therapies

期刊

NUCLEUS
卷 5, 期 1, 页码 47-55

出版社

TAYLOR & FRANCIS INC
DOI: 10.4161/nucl.27928

关键词

nucleus; nuclear organization; nuclear envelope; barrier-to-autointegration factor; vaccinia-related kinase; cell cycle; cancer; anti-mitotics; drug discovery

向作者/读者索取更多资源

Current anti-cancer therapies have a great deal of undesirable side effects; therefore, there is a need to develop efficient and cancer cell-specific new drugs without strong dose-limiting side effects. In my opinion, mechanisms of nuclear assembly and organization represent a novel platform for drug targets, which might fulfill these criteria. The nuclear stiffness and organization of some cancer types are often compromised, making them more vulnerable for further targeting the mechanisms of nuclear integrity than their normal counterparts. Here I will discuss the nuclear organization of normal cells and cancer cells, the molecular mechanisms that govern nuclear assembly with emphasis on those that, in my view, might be considered as targets for future anti-cancer therapies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据